A glioblastoma diagnosis puts you under real time pressure. Surgery, radiation, chemotherapy - the sequence moves quickly, and the instinct is to keep up. A second opinion can feel like a delay you cannot afford. It is not. For a tumor as complex as glioblastoma, the two or three weeks it takes to get an expert review at a specialized center often yields information that changes what treatment looks like - and sometimes what treatment is possible.
This guide is for the patient or caregiver who has a diagnosis in hand and wants to know exactly how to use a second opinion well. It covers what to collect, what to ask, and what to do when two centers give you different answers.
What should you gather for a glioblastoma second opinion?
The reviewing team needs to form an independent judgment, not just react to what they are told. That requires actual source material: tissue, imaging files, and clinical documentation. A summary letter from your current oncologist is useful, but it is not a substitute for the primary records below.
- Pathology slides and tissue block. The physical glass slides from your biopsy or resection, or the paraffin-embedded tissue block, matter most. Contact the pathology department at the hospital where your surgery took place and request a release. Most centers will mail the slides directly to the reviewing center once you provide a mailing address and written consent.
- The full pathology report. It should include the WHO grade, IDH mutation status (a gene change that affects prognosis), MGMT promoter methylation status (which affects how well temozolomide chemotherapy works), and any additional molecular markers tested. If your report is missing these, ask your oncologist whether comprehensive testing was done. Our guide to what your glioblastoma pathology report really means explains each marker in plain language.
- All MRI scans - not just the most recent one. Request DICOM files (the raw image data) on a USB drive or via a secure file-sharing link. These are much more useful to a neuroradiologist than printed films or a PDF. Include pre-operative scans, post-operative scans, and any follow-up imaging since surgery.
- All radiology reports. Get a written report for each MRI. Include these with the DICOM files so the reviewing radiologist can see what the original reader documented and where interpretations may have differed.
- Operative report from surgery. If you had a resection or biopsy, this document records what the surgeon found, how much tumor was removed, whether complications occurred, and what surgical approach was taken.
- Clinic and consultation notes. Gather summary letters from your neurosurgeon, neuro-oncologist, and radiation oncologist. These show the reviewing team your current treatment plan.
- Current medication list. List all drugs - cancer-related and otherwise - with dosages and how long you've been on each. Include steroids like dexamethasone, which affect brain imaging and how surgery is planned.
- Insurance or funding information. If the reviewing center charges a fee for pathology consultation or a remote review, ask in advance whether your insurer covers it and whether you need pre-authorization.
The American Brain Tumor Association recommends gathering pathology materials and imaging before any specialist appointment, noting specifically that a neuropathologist who knows brain tumors - not a general pathologist - should review the slides, and that this review should happen at a large academic center with a dedicated neuro-oncology division.
Why a second opinion changes more than you might expect
This is not about distrust. It is about glioblastoma being complex at the molecular level. Local oncologists may see only a handful of cases a year, while specialists see many more. This means local oncologists can miss details that specialists catch regularly.
The National Brain Tumor Society notes that centers treating many glioblastoma patients stay current on new protocols and are better at spotting rare molecular subtypes. Sometimes a second opinion on pathology alone changes the WHO grade or reveals a molecular variant that affects which therapies or clinical trials you can try.
Imaging is worth another look. Research in Cancer Medicine found that expert neuroradiologists often disagreed with the original reports - sometimes finding tumors were bigger than first thought. An underestimated tumor affects both surgical planning and the radiation treatment that follows.
A broader analysis of second opinions across oncology, published in PLOS ONE, found that treatment plans changed for many patients, which could affect their prognosis. The authors concluded that second opinions matter and that doctors should encourage patients to seek them.
Where to seek a glioblastoma second opinion
Not every second opinion carries equal weight. For glioblastoma specifically, look for centers that meet at least two of the following criteria:
- A dedicated neuro-oncology program at an NCI-designated comprehensive cancer center
- A multidisciplinary tumor board that regularly brings together a neuropathologist, a neuroradiologist, a neurosurgeon, a neuro-oncologist, and a radiation oncologist to review cases together
- Active glioblastoma clinical trials - a sign the center does current research and knows about new options
- Comprehensive molecular profiling capabilities beyond standard MGMT and IDH testing, such as next-generation sequencing panels that identify rarer actionable mutations
The National Cancer Institute advises that if a neurosurgeon won't refer you to a colleague for a second opinion, that's a red flag. A specialist with real experience knows other experts and will recommend them.
Many major academic centers offer remote pathology review for patients who can't travel. Memorial Sloan Kettering Cancer Center, for example, offers pathology consultation for patients outside New York. Dana-Farber and Mayo Clinic have similar services. For patients considering options in different countries, our article on international pathology second opinions for glioblastoma covers how to work with remote slide review across borders - including what file formats different centers accept and how to transfer consent internationally.
Questions to bring to the appointment
A second opinion works best when you bring written questions. Bring your list on paper, take notes, or ask permission to record the conversation. The American Brain Tumor Association's question guide is a good place to start. Here is a set of questions for glioblastoma specifically.
About the diagnosis
- Do you agree with the WHO grade and molecular classification in my pathology report?
- Has my MGMT promoter methylation status been confirmed? How does it affect the chemotherapy recommendation?
- Are there molecular markers not yet tested that you would recommend, given my tumor profile?
- Is the extent of tumor on MRI consistent with what you see on independent review?
About the proposed treatment plan
- Is the planned surgical approach and extent of resection appropriate for my tumor's location and size?
- Are techniques like fluorescence-guided surgery or awake craniotomy available here, and could they let you safely remove more tumor?
- Do you recommend Tumor Treating Fields alongside chemoradiation for my specific case?
- How many patients with my tumor type and location does your team treat each year?
- Am I eligible for any clinical trials based on my molecular profile?
About planning ahead
- How much time can I take before starting treatment without affecting outcomes?
- If first-line treatment does not control the tumor, what are the realistic next options?
- What does my molecular profile suggest about how this tumor is likely to behave over time?
How to evaluate two different recommendations
When the second opinion matches the first, that is reassuring. You can move forward knowing two independent teams reached the same conclusion independently. When they differ, the path forward is harder - but still possible.
Start by identifying whether the disagreement is about diagnosis or treatment. A disagreement about the diagnosis - if one center grades the tumor differently or finds a molecular marker the other missed - matters more. One review might be incomplete. In that case, get a third opinion from a neuropathologist before you commit to a treatment plan.
A treatment disagreement is more common and often reflects real debate in the field. Glioblastoma treatment involves discussion about questions like how aggressively to operate near eloquent cortex (the brain regions controlling speech and movement), when to add Tumor Treating Fields, and which clinical trials best fit a patient with your molecular profile. When recommendations differ on these points, ask each team to explain the evidence behind their position and the known trade-offs. Ask both centers for a written summary so you can compare them side by side without relying on memory.
If you are considering options in different countries and need a senior review without traveling, you can arrange a remote second opinion through Art of Healing Cancer, which coordinates specialist review of pathology and imaging for international patients and can help you understand what two different recommendations mean for your situation.
Making the most of a remote second opinion
You don't need to fly to a major cancer center to get expert input. Most leading neuro-oncology programs now accept remote consultations - but the quality of the review depends entirely on the quality of the records you send.
For a remote review to work, the receiving center needs DICOM files (not screenshots or printed films), a complete pathology report with all molecular markers, and a clear clinical summary. Ask the reviewing center how they want files delivered and whether they can receive a physical paraffin tissue block or need scanned slide images instead. Confirm the turnaround time and what format the opinion will take - a written report is better than a brief verbal summary.
If you are a caregiver managing all this while supporting the patient, our guide to your first 30 days after a glioblastoma diagnosis gives a step-by-step guide for the first weeks - including how to build the records package while starting treatment conversations. When you're ready, you can also upload MRI files and pathology reports and request a remote case review through the Glioblastoma Center patient journey form.
When to talk to your doctor
Talk to your current oncologist before requesting your records - they can often help coordinate the transfer and may know which centers have the most experience with your tumor. If your case hasn't been reviewed by a multidisciplinary tumor board, ask whether that can happen before the second opinion appointment; it may answer some of your questions early. If you feel your team is actively discouraging a second opinion, remember: experienced neuro-oncologists welcome a second opinion, and you have the right to copies of your own medical records.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.